Article
Completed suicides of citalopram users-the role of CYP genotypes and adverse drug interactions.
International journal of legal medicine - 1 Mar 2019
Rahikainen Anna-Liina, Vauhkonen P, Pett H, Palo J U, Haukka J, Ojanperä I, Niemi M, Sajantila Antti
Abstract excerpt
Depression is known to be a risk factor for suicide. Currently, the most used antidepressants are selective serotonin reuptake inhibitors (SSRIs). Not all users, however, benefit from them. In such cases, treatment failure can be explained in part by genetic differences. In this study, we investigated the role of pharmacogenetic factors in citalopram-positive completed suicides (n = 349). Since citalopram is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
